In July Kymos had a general site inspection by the FDA. The inspection was closed succesfully and the corresponding EIR letter was issued.



In November 2016, the company acquired a CRO in Italy called PHARMAPROGRESS. The company was located in Ancona and it was a staff of 8 people. This company had a 700 m2 of laboratories for analytical development of APIs and FDFs and bioanalysis. Nowadays the company has completed the integration process to KYMOS and has grown to 14 people.

Pharmaprogress façade


In January 2015, the company moved its facilities from Barcelona (Barcelona Science Park) into a stand-alone buiding located in Cerdanyola del Vallès (Valles Technology Park). A brand new laboratory was built increasing the surface from 650 m2 to 1.500 m2. This circumtance allowed the company to have an important increase of turnover and staff during 2015 and 2016. This same year KYMOS obtained the importer's autorization for medicinal products. Batch release services for marketin gproducts were implemented.

Kymos site


In January 2012, KYMOS reached an agreement to take over an immunology department of a former R&D center that the French multinational group IPSEN had in Barcelona. Thanks to this deal KYMOS created a new biological division. Experienced people, instruments and know-how were transferred to Kymos and both companies signed a long-term collaboration agreement to jointly develop innovative drugs.

Ipsen&Kymos contract signature


In 2011 KYMOS built a microbiology laboratory and extended its GMP certification to microbiological testing of non-sterile products. This certification was extended later again in 2016 to sterile products.

Kymos 2011 team


In 2009 the company obtained the GMP and the authorization as Manufacturer (partial manufacturer for quality control activities). From now on KYMOS moved all CMC activities (mainly analytical development and stability studies) to GMP quality system and begun to provide quality control services for APIs and FDF.

GMP certificate


The company obtained the GLP certification in 2002 at the very begining. The first projects were in the domain of metabolism and bioanalysis. 


KYMOS was founded in 2001 by a group of  professionals with more than 10 years of experience in research and development areas of pharmaceutical industry. The staff members were clients before being service providers achieving a deep knowledge of the pharma company requirements and priorities. This experience allowed KYMOS a fast start-up of the company despite being in this high competitive market. The company was initially settled up in Barcelona Science Park, expanding up from one to four different labs in few years.

Kymos foundation team